STAAR Surgical

Alcon and STAAR Surgical announced the postponement of STAAR’s Special Meeting of Stockholders regarding their proposed merger. Originally scheduled for October 23, 2025, it’s now set for November 6, 2025. The record date for voting eligibility remains September 12, 2025. The merger aims to strengthen Alcon’s refractive surgery market position through STAAR’s ICL technology. Analysts suggest regulatory reviews and due diligence contributed to the delay. The combined entity anticipates innovation in intraocular lens technology but faces integration challenges and market competition.

STAAR Surgical (STAA) will release its Q2 2025 financial results on August 6, 2025, after market close. A live webcast and earnings call will follow at 4:30 p.m. ET. The company, a leader in phakic IOLs like the EVO ICL™, aims to reduce dependence on glasses and contacts. STAAR has distributed over 3 million ICLs across 75+ countries. A replay will be available on STAAR’s investor relations website for 90 days.